Rubicon Research Outpaces Pharma Giants With 75.9% CAGR — Beating Sun, Dr. Reddy’s, And Lupin On Growth And Returns
As Rubicon Research opens its INR 1,377.5 crore initial public offering (IPO) — scheduled from 9 October to 13 October 2025 — investor attention is firmly centered on one question: how does this fast-growing mid-cap challenger compare with India’s established pharmaceutical giants? This offering, comprising a INR 500 crore fresh issue and an INR 877.5 […]








